Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 19,167 | 9,595 | N/A |
| Marketable Securities | 2,626 | 1,847 | N/A |
| Other current assets | 628 | 152 | 0 |
| TOTAL | $22,421 | $11,594 | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,168 | 773 | N/A |
| Other Non-Current Assets | 849 | 454 | 0 |
| TOTAL | $3,016 | $1,227 | $N/A |
| Total Assets | $25,437 | $12,820 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 806 | 208 | 0 |
| Accrued Expenses | 170 | 69 | N/A |
| Other current liabilities | 833 | 0 | N/A |
| TOTAL | $1,810 | $277 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 3,866 | 5,036 | 0 |
| TOTAL | $4,520 | $5,036 | $N/A |
| Total Liabilities | $6,330 | $5,314 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 5 | 5 | N/A |
| Retained earnings | -6,979 | -3,681 | N/A |
| Other shareholders' equity | 6,943 | 6,935 | 0 |
| TOTAL | $19,108 | $7,507 | $N/A |
| Total Liabilities And Equity | $25,438 | $12,820 | $0 |